Improving expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 90卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [21] Adoptive Therapy With Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
    Riddell, Stanley R.
    Sommermeyer, Daniel
    Berger, Carolina
    Liu, Lingfeng
    Balakrishnan, Ashwini
    Salter, Alex
    Hudecek, Michael
    Maloney, David G.
    Turtle, Cameron J.
    CANCER JOURNAL, 2014, 20 (02): : 141 - 144
  • [22] Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy
    Y Huang
    D Li
    D-Y Qin
    H-F Gou
    W Wei
    Y-S Wang
    Y-Q Wei
    W Wang
    Gene Therapy, 2018, 25 : 192 - 197
  • [23] Strategies to Improve the Clinical Performance of Chimeric Antigen Receptor-Modified T Cells for Cancer
    Zhang, Qing
    Li, Huizhong
    Yang, Jie
    Li, Liantao
    Zhang, Baofu
    Li, Jia
    Zheng, Junnian
    CURRENT GENE THERAPY, 2013, 13 (01) : 65 - 70
  • [24] Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy
    Wang, Xingbing
    Gottschalk, Stephen
    Song, Xiao-Tong
    BLOOD, 2014, 124 (21)
  • [25] Galunisertib enhances chimeric antigen receptor-modified T cell function
    Wang, Zhixiong
    Liu, Qian
    Risu, Na
    Fu, Jiayu
    Zou, Yan
    Tang, Jiaxing
    Li, Long
    Liu, Hui
    Zhou, Guomin
    Zhu, Xuekai
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 3 - 13
  • [26] Efficient derivation of chimeric-antigen receptor-modified TSCM cells
    Kranz, Emiko
    Kuhlmann, Charles J.
    Chan, Joshua
    Kim, Patrick Y.
    Chen, Irvin S. Y.
    Kamata, Masakazu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
    Globerson-Levin, Anat
    Waks, Tova
    Eshhar, Zelig
    MOLECULAR THERAPY, 2014, 22 (05) : 1029 - 1038
  • [28] Chimeric antigen receptor-modified T cells against several target antigens in multiple myeloma
    Chang, Lung-Ji
    Liu, Yuchen
    Kuo, Hao-Hsiang
    Tsao, Shih-Ting
    Moreb, Jan S.
    CANCER RESEARCH, 2015, 75
  • [29] Chimeric Antigen Receptor-Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond
    Riddell, Stanley R.
    Jensen, Michael C.
    June, Carl H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S2 - S5
  • [30] Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
    Berger, Carolina
    Sommermeyer, Daniel
    Hudecek, Michael
    Berger, Michael
    Balakrishnan, Ashwini
    Paszkiewicz, Paulina J.
    Kosasih, Paula L.
    Rader, Christoph
    Riddell, Stanley R.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 206 - 216
12345